Series A - AEENA Dx
Investment Firm
Overview
AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases
Announced Date
Jun 25, 2019
Funding Type
Series A
Highlights
Location
United States, North America
Social
N/A
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Nola Masterson |
 Portfolia |
Round Details and Background
AEENA Dx raised an undisclosed amount on 2019-06-25 in Series A
AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 01, 2022 |  Series A - AEENA Dx | 1 | - | undefined |
| Jul 16, 2013 | Seed Round - AEENA Dx | 1 | - | undefined |
| Jan 14, 2014 | Debt Financing - AEENA Dx | - | 324.7K | |
| Dec 27, 2011 | Seed Round - AEENA Dx | - | 192.0K |
Recent Activity
There is no recent news or activity for this profile.